Health and Fitness Health and Fitness
Fri, October 14, 2011
[ Fri, Oct 14th 2011 ] - Market Wire
DPM Third Quarter 2011 Results

Dynavax to Present at Newsmakers in the Biotech Industry Conference


Published on 2011-10-14 09:36:03 - Market Wire
  Print publication without navigation


October 14, 2011 12:27 ET

Dynavax to Present at Newsmakers in the Biotech Industry Conference

BERKELEY, CA--(Marketwire - Oct 14, 2011) - Dynavax Technologies Corporation (NASDAQ: [ DVAX ]) announced today that it plans to present at the NewsMakers in the Biotech Industry Conference in New York on Friday, October 21, 2011 at 10:00 a.m. EDT (7:00 a.m. PDT).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a corporate overview presentation. To access the live webcast and the subsequent archived recording of the presentation, please log onto Dynavax's website at [ http://investors.dynavax.com/newsevents.cfm ].

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit [ www.dynavax.com ].


Contributing Sources